However, a favorable role of K. pneumoniae in clinical cancer immunotherapy has been studied: Matson et al. studied the association of the microbiota composition and the responses to PD-1 blockade in 42 metastatic melanoma patients and found that K. pneumoniae were more abundant in the fecal samples from responders [40]. The gene discussed is PDCD1; the disease is metastatic melanoma.